CEMI - Chembio Diagnostics GAAP EPS of $0.47 beats by $0.67 revenue of $20.6M beats by $7.05M March, 03 2022 04:11 PM Chembio Diagnostics Inc. Chembio Diagnostics press release (NASDAQ:CEMI): Q4 GAAP EPS of $0.47 beats by $0.67. Revenue of $20.6M (+101.6% Y/Y) beats by $7.05M. For further details see: Chembio Diagnostics GAAP EPS of $0.47 beats by $0.67, revenue of $20.6M beats by $7.05M